Tag: Renin angiotensin system

An estimated 116 million adults in the United States have high blood pressure, and many rely on medications like Losartan to manage their condition. For some, this raises a concerning question: can losartan cause memory loss? The answer is nuanced, with some preclinical evidence suggesting a risk from related hypotension, while other studies highlight the drug's potential for cognitive protection.

According to the American Academy of Family Physicians, aliskiren (Tekturna) was the first direct renin inhibitor approved for hypertension. Yes, Tekturna is a direct renin inhibitor, representing a unique pharmacological approach to managing high blood pressure by blocking the renin-angiotensin-aldosterone system at its initial step.

It is well-established that generic medications provide the same clinical benefits as their brand-name counterparts, often at a lower cost. For those prescribed the brand-name drug Avapro, understanding its generic alternative is crucial, as the generic name for Avapro is irbesartan.

According to the Centers for Disease Control and Prevention, ACE inhibitors are among the most commonly prescribed medications for controlling high blood pressure and heart conditions. To understand **what does ACE do to your body**, one must first look at the role of the angiotensin-converting enzyme in regulating cardiovascular function.

Affecting nearly one-third of American adults, anxiety disorders are widespread. While primarily prescribed for cardiovascular health, emerging research on valsartan explores whether it helps with anxiety, though it is not a primary anxiety treatment. This article unpacks the scientific evidence surrounding the potential link between valsartan and anxiety.

Nearly half of all adults in the United States have hypertension. For those managing this condition, understanding **how does benazepril work?** provides key insight into its effectiveness, as this medication plays a crucial role in lowering blood pressure and reducing cardiovascular risk.

As an angiotensin II receptor blocker, eprosartan is distinguished by its unique, non-biphenyl, non-tetrazole chemical structure. The action of eprosartan involves a dual mechanism to lower blood pressure effectively, targeting the renin-angiotensin system (RAS) and inhibiting norepinephrine production. This comprehensive overview details the pharmacological specifics of this antihypertensive medication.

With a plasma half-life of only 15–30 seconds, bradykinin is a potent peptide whose biological effects are tightly controlled by rapid enzymatic destruction. The primary enzyme responsible for this rapid inactivation is angiotensin-converting enzyme (ACE), but it is not the only one. This article explores the specific enzymes involved and the medical implications when the system that naturally destroys bradykinin is inhibited.